Shortcut Navigation:


Updated 07/06/2012

This site features information on Oncotype DX™, a breast cancer test from Genomic Health that can help individualize breast cancer treatment. Oncotype DX predicts the likelihood of breast cancer recurrence in women with newly diagnosed, early stage invasive breast cancer, and assesses the benefit from certain types of chemotherapy. This information can help doctors tailor breast cancer treatment on an individual basis.